Last updated: 23 June 2021 at 5:37pm EST

Carman Alenson Net Worth




The estimated Net Worth of Carman Alenson is at least $521 Thousand dollars as of 21 June 2021. Carman Alenson owns over 1,777 units of Agios Pharmaceuticals Inc stock worth over $78,739 and over the last 8 years Carman sold AGIO stock worth over $441,835.

Carman Alenson AGIO stock SEC Form 4 insiders trading

Carman has made over 15 trades of the Agios Pharmaceuticals Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently Carman exercised 1,777 units of AGIO stock worth $91,533 on 21 June 2021.

The largest trade Carman's ever made was exercising 3,590 units of Agios Pharmaceuticals Inc stock on 14 February 2020 worth over $159,073. On average, Carman trades about 822 units every 52 days since 2016. As of 21 June 2021 Carman still owns at least 1,777 units of Agios Pharmaceuticals Inc stock.

You can see the complete history of Carman Alenson stock trades at the bottom of the page.



What's Carman Alenson's mailing address?

Carman's mailing address filed with the SEC is C/O AGIOS PHARMACEUTICALS INC., 88 SIDNEY STREET, CAMBRIDGE, MA, 02139.

Insiders trading at Agios Pharmaceuticals Inc

Over the last 11 years, insiders at Agios Pharmaceuticals Inc have traded over $77,887,085 worth of Agios Pharmaceuticals Inc stock and bought 3,229,562 units worth $154,554,190 . The most active insiders traders include Kevin P Starr, Robert Nelsen, and John Maraganore. On average, Agios Pharmaceuticals Inc executives and independent directors trade stock every 9 days with the average trade being worth of $765,588. The most recent stock trade was executed by Rahul D. Ballal on 11 August 2024, trading 2,302 units of AGIO stock currently worth $102,002.



What does Agios Pharmaceuticals Inc do?

at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible



What does Agios Pharmaceuticals Inc's logo look like?

Agios Pharmaceuticals Inc logo

Complete history of Carman Alenson stock trades at Agios Pharmaceuticals Inc

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
21 Jun 2021 Carman Alenson
Principal Accounting Officer
Option 1,777 $51.51 $91,533
21 Jun 2021
1,777
16 Apr 2021 Carman Alenson
Principal Accounting Officer
Sale 1,118 $55.89 $62,485
16 Apr 2021
0
15 Apr 2021 Carman Alenson
Principal Accounting Officer
Sale 991 $54.00 $53,514
15 Apr 2021
1,118
22 Feb 2021 Carman Alenson
Principal Accounting Officer
Option 692 $53.84 $37,257
22 Feb 2021
1,994
14 Feb 2021 Carman Alenson
Principal Accounting Officer
Option 1,679 $55.89 $93,839
14 Feb 2021
1,863
2 Sep 2020 Carman Alenson
Principal Accounting Officer
Sale 250 $39.93 $9,983
2 Sep 2020
184
2 Mar 2020 Carman Alenson
Principal Accounting Officer
Sale 345 $47.30 $16,319
2 Mar 2020
184
26 Feb 2020 Carman Alenson
Principal Accounting Officer
Sale 472 $47.12 $22,241
26 Feb 2020
184
22 Feb 2020 Carman Alenson
Principal Accounting Officer
Option 691 $53.11 $36,699
22 Feb 2020
875
20 Feb 2020 Carman Alenson
Principal Accounting Officer
Sale 2,427 $53.37 $129,529
20 Feb 2020
184
14 Feb 2020 Carman Alenson
Principal Accounting Officer
Option 3,590 $51.51 $184,921
14 Feb 2020
3,774
26 Dec 2019 Carman Alenson
Principal Accounting Officer
Sale 2,950 $50.09 $147,766
26 Dec 2019
184
5 Sep 2018 Carman Alenson
Principal Accounting Officer
Option 312 $52.29 $16,314
5 Sep 2018
464
9 Jul 2018 Carman Alenson
Principal Accounting Officer
Option 272 $52.29 $14,223
9 Jul 2018
272
12 Jan 2018 Carman Alenson
Principal Accounting Officer
Option 2,150 $52.29 $112,424
12 Jan 2018
2,150


Agios Pharmaceuticals Inc executives and stock owners

Agios Pharmaceuticals Inc executives and other stock owners filed with the SEC include: